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A B S T R A C T
Invasive pulmonary aspergillosis is increasingly described in non-neutropenic patients, such as patients with
COPD receiving corticosteroids and the critically ill. Here, we present a case of a lethal pulmonary Aspergillus
niger infection in a COPD patient. Immunological tests showed an impaired innate and adaptive immune re-
sponse to Aspergillus. A history of COPD, unresponsiveness to antibiotics and especially a suggestive CT-scan
should trigger the clinician to consider diseases caused by Aspergillus.
1. Introduction
Invasive pulmonary aspergillosis (IPA), deﬁned as lung parenchyma
invasion and necrosis due to Aspergillus, is known to be a life-threa-
tening infection in severely immunocompromised patients with sig-
niﬁcant mortality of 25–50% [1,2]. IPA has been increasingly reported
in non-neutropenic patients, such as patients with COPD receiving
corticosteroids, decompensated liver cirrhosis, and patients in the in-
tensive care unit (ICU) [3–5]. The diagnosis of IPA in non-neutropenic
patients is more challenging because signs and symptoms are often non-
speciﬁc, risking delayed diagnosis. Here, we describe a case of lethal
pulmonary aspergillosis due to Aspergillus niger complex in a COPD
patient and studied the innate and adaptive immune response. Fur-
thermore, we reviewed the microbiological characteristics of invasive
pulmonary A. niger complex infections.
2. Case
A 55-year-old woman was admitted to a district hospital (day 0)
with progressive cough and hemoptysis for four days. She had no re-
levant prior medical history other than COPD Gold II, recently diag-
nosed and yet untreated, and she was a heavy smoker. A chest X-ray
performed on day 0 showed a cavitary lesion in the apex of the left lung,
suggestive for tuberculosis. A broncho-alveolar lavage (BAL) was
performed on day +1. Ziehl-Neelsen staining for Mycobacteria was
negative. Pending sputum and BAL cultures, the patient received
amoxicillin/clavulanic acid and was discharged from the hospital. On
day +5, she presented to the emergency department of the same dis-
trict hospital with fever, thoracic pain and severe dyspnea. Blood panel
showed leukocytosis (26.5∙109/L (4.0–10.0∙109/L) with 89% poly-
morphonuclear cells (PMN)), C-reactive protein (CRP) of 436mg/L
(< 10mg/L), a creatinin level of 282μmol/L (45–80μmol/L) and lac-
tate of 2.7mmol/L (0.5–1.6mmol/L). The sputum and BAL cultures
taken on day + 1 grew solely A. niger, which was considered con-
tamination. The patient was admitted and treated with intravenous
broad-spectrum antibiotics (ﬂucloxacillin 1000mg q8h and cipro-
ﬂoxacin 400mg q12h) as well as prednisone 50mg q24h for exacer-
bation of COPD. On the same day, she was transferred to the ICU due to
progressive respiratory failure and hemodynamic instability, requiring
mechanical ventilation and hemodialysis. A thoracic computed tomo-
graphy (CT) showed severe consolidations with cavities in the apex of
the left lung and apical bullae in the right lung, parenchymal damage
and pleural thickning (Fig. 1A). A CT-guided aspiration of one of the
cavities revealed hyphae, suggestive for Aspergillus. The extensive ca-
vitation, pleural thickening and parenchymal damage on the CT scan
suggested either a previously undiagnosed chronic cavitary pulmonary
aspergillosis (CCPA), presenting with an acute exacerbation, or a sub-
acute invasive aspergillosis (SAIA).
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That same day (day + 5), intravenous voriconazole 200mg q12h
was started. Blood cultures remained negative. On day +7 she was
transferred to our university medical center ICU due to progressive
renal failure for which she needed continuous veno-venous hemoﬁl-
tration (CVVH). At arrival, she required volume controlled mechanical
ventilation, with FiO2 of 90% for 95% oxygen saturation, and had a
respiratory acidosis with severe hypercapnia (pCO2 10.3 kPa
(4.7–6.4kPa)). Since it was not possible to decrease FiO2, the patient
was ventilated in prone position, initially with good response. A follow-
up CT-scan on day +9 showed increased destruction of the left lung.
The antibiotic regimen was switched to piperacillin/tazobactam 4000/
500mg q12h intravenously and the corticosteroids were tapered down.
During admission at our ICU, the patient produced excessive amounts
of brown sputum, over 500mL/day. Consecutive sputum cultures taken
at our hospital all grew A. niger. The A. niger isolate cultured from the
BAL on day +1 and all following isolates tested resistant to vor-
iconazole using epidemiological cut-oﬀ values of 2mg/L according to
EUCAST (A. nigerminimum inhibitory concentration (MIC) 4mg/L). On
day +10, based on the susceptibility testing results, antifungal treat-
ment was switched to intravenous liposomal amphotericin B 3mg/kg
q24h (MIC 0.5mg/L). As respiratory failure progressed, intravenous
micafungin 100mg q24h was added on day + 12.
Standard immunological tests were performed on day + 8 to de-
termine possible underlying immune deﬁciencies. Auto-antibody tests,
HIV serology, white blood cell count (diﬀerential values and CD4+ ),
complement system markers (CH50 and AP50), and immunoglobulins
(IgA, IgM and IgG including subclasses) showed no abnormalities.
On day + 25, the patient became progressively hemodynamically
unstable. Due to lack of respiratory improvement and poor prognosis, it
was decided in accordance with the family to cease treatment. The
patient was extubated and died soon thereafter. Autopsy was not al-
lowed.
3. Discussion
3.1. Microbiological characteristics of Aspergillus niger
Aspergillus spores are amongst the dominant fungal components
found during air sampling. The primary route of human infection is via
inhalation of airborne conidia, which easily reach the pulmonary al-
veoli, due to their small size of 2–3 µm [6]. Aspergillus fumigatus is the
most common species recovered from cases of invasive aspergillosis. It
has more favorable characteristics (smaller size of conidia, more ther-
motolerant) than Aspergillus niger, Aspergillus ﬂavus, and Aspergillus ter-
reus, that are responsible for 8–9% of cases [7,8]. Taxonomy of A. niger
complex is challenging as black-spored aspergilla are diﬃcult to dis-
tinguish morphologically. Using sequencing techniques, isolates can be
further divided into 19 diﬀerent taxa, grouped into 5 main clades of
Fig. 1. A. Pulmonary CT-scan on day + 5 of admission showing dense alveolar consolidations in the apex of the left lung with multiple central and subpleural ﬂuid ﬁlled cavities and
apical bullae in the right lung. B. Calcium oxalate crystal deposition in bronchial debris obtained during broncho-suction. Magniﬁcation 400× ; H&E stain. C. Innate and adaptive
cytokine response to A. niger. IL-1β, TNFα, IL-6, IL-1Ra (top), IL-17, IL-22 and IFNγ (bottom) levels measured by ELISA in culture supernatants of PBMCs isolated from a healthy volunteer
(black bars) and patient (grey bars) stimulated with live (top) or heat-inactivated (bottom) A. niger conidia for 24 h (top) or 7 days (bottom). D. Functional assessment of the antifungal
host response. Top: IL-1β and TNFα measured by ELISA in culture supernatants of PBMCs isolated from a healthy volunteer (black bars) and patient (grey bars) stimulated for 24 h with
LPS, Pam3Cys, β-glucan and β-glucan/Pam3Cys combination. Bottom left: Percentage of FITC-positive neutrophils measured by ﬂowcytometry after 20min exposure to FITC-labeled A.
fumigatus conidia or C. albicans blastoconidia. Bottom right: Fungal killing capacity, measured by counted CFUs on sabouraud agar plated after exposure of live A. niger (1×105 conidia)
to neutrophils (1×106 conidia) from a healthy volunteer (black dots) and patient (grey dots) for 24 h.
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which A. awamori, A. tubingensis and A. niger are most often isolated
from clinical samples [9]. Historically, A. niger complex has been pri-
marily associated with otomycosis and cutaneous infections. However,
an increasing incidence of invasive pulmonary infections with A. niger
was reported recently [8].
The virulence of Aspergillus is multifactorial and depends on both
the immune status of the patient and the biological characteristics of
the fungus. A. niger produces oxalic acid (oxalate) as part of its fer-
mentation process; a feature only rarely described in other Aspergillus
species [10]. Pyruvate, the end product of glycolysis, is ﬁrst trans-
formed to oxaloacetate. Then, oxaloacetate acetylhydrolase, located in
the cytoplasm of A. niger, catalyzes the hydrolysis of oxaloacetate to
oxalate and acetate. In the human body, oxalate precipitates with cal-
cium, forming calcium oxalate crystals. These depositions cause tissue
damage and necrosis due to obstruction in blood vessels and direct
cytotoxicity through oxidative stress [10]. Rapidly developing pul-
monary necrosis due to the destructive nature of calcium oxalate pro-
duced by A. niger complex [11] as well as acute renal failure due to
calcium oxalate crystal deposition [12] have been reported.
In our patient, tissue obtained during bronchoscopy was described
as necrotic with excessive crystal-like structures (Fig. 1B). In addition,
our patient produced excessive amounts of brown sputum, which has
been reported in A. niger complex infections [11]. Our clinical chem-
istry department conﬁrmed large amounts of calcium oxalate crystals
present in the sputum, which unfortunately was not quantiﬁed. As
calcium oxalate crystals are hypertonic, this provides a possible ex-
planation for the excessive sputum production. The appearance of black
or dark brown sputum with the presence of calcium oxalate crystals on
pathological examination may thus be a key feature in the diagnosis of
A. niger infection. As our patient was anuric, it was not possible to
examine a urine sample for the presence of calcium oxalate crystals.
3.2. Immunological defense mechanisms against Aspergillus niger invasion
The ﬁrst defense against inhaled Aspergillus conidia begins with
their removal by the ciliary action of the mucosal respiratory epithe-
lium. Damage to pulmonary epithelial cells due to inﬂammation,
chronic lung diseases, drugs, chemotherapy, or graft-versus-host dis-
ease result in a compromised physical barrier against inhaled fungi. It is
now recognized that ICU patients are also prone to IPA. Apart from a
critical illness-induced suppressed immunity, mechanical ventilation
reduces ﬁrst line defense of airway clearance and might allow free
passage of fungi into the lower segments of the lung [4]. In COPD,
impaired ciliary function and chronic inﬂammation reduce the capacity
to clear fungal spores from the lungs and thus provide a natural en-
vironment that has a predilection for Aspergillus colonization and bio-
ﬁlm formation [13]. Still, it remains unclear why some COPD patients
are benignly colonized with Aspergillus, whereas other patients develop
subacute invasive aspergillosis (SAIA).
To investigate whether the severity of the infection in our patient
could be attributed to an immune defect, we tested her A. niger innate
and adaptive immune responses. First, peripheral blood mononuclear
cells (PBMCs) were isolated and stimulated with A. niger CBS 101,706
live conidia and heat killed 1×107 conidia/mL. A slightly lower, but
comparable innate cytokine response of our patient to live A. niger
conidia was observed when compared to a healthy volunteer. (Fig. 1C).
The function of several pattern recognition receptors, known to be
involved in the antifungal host defense to A. fumigatus [14], was in-
vestigated by stimulating PBMCs with speciﬁc ligands, including (li-
popolysaccharide) LPS (TLR4), lipopeptide Pam3Cys (TLR2), β-glucan
(dectin-1) and a combination of Pam3Cys/β-glucan. PBMCs of the pa-
tient demonstrated an adequate response to stimulation of TLR2
(Fig. 1D). It is known that TLR2 synergizes with dectin-1 [15] that can
be observed by stimulating PBMCs with the combination of Pam3Cys
and β-glucan (Fig. 1C). Although this synergistic eﬀect was not ob-
served in IL-1β production, it could be observed for TNFα. In contrast,
stimulation with the TLR4 agonist LPS revealed much less cytokine
induction indicating a possible impaired TLR4 function (Fig. 1D). In
addition, we observed completely impaired T-helper cytokine produc-
tion in response to A. niger, whereas the control produced signiﬁcant
concentration of T helper cytokines (Fig. 1C).
Impaired neutrophil phagocytosis and killing, as seen in chronic
granulomatous disease, might also play a role in the severity of the
disease in our patient. PMNs were isolated from whole blood by hy-
potonic lysis. PMNs of the patient and a healthy volunteer were in-
cubated with ﬂuorescein isothiocyanate (FITC)-labeled A. fumigatus
V05–27 (heat killed) and FITC-labeled heat-killed Candida albicans
ATCC MYA-3573 (UC 820) at a ﬁnal concentration of 2.5× 107 /mL in
a volume of 200 μL for 30min at 37 °C and 5% CO2. The percentage of
neutrophils that phagocytosed the fungi was quantiﬁed by a FC 500
ﬂowcytometer. Fig. 1D shows 12% less FITC-positivity of the patient
neutrophils compared to the healthy control when exposed to A. fu-
migatus, suggesting a slightly lower capacity to phagocytose A. fumi-
gatus. Additionally, PMNs were co-cultured with live A. niger conidia
(1×106) to investigate the killing capacity of the patient's neutrophils.
After 24 h incubation at 37 °C and 5% CO2 higher numbers of colony
forming units (CFUs) were counted in the patient's cells, indicating a
decreased killing ability compared to healthy control. As corticosteroids
are known to impair (monocyte) phagocytosis of Aspergillus spp. [16], it
can therefore not be determined with certainty that our patient had a
previously undiagnosed immune deﬁciency.
4. Conclusion
Invasive pulmonary aspergillosis is increasingly observed in non-
neutropenic patients who appear only moderately im-
munocompromised. We presented a case of pulmonary aspergillosis,
caused by Aspergillus niger complex, most likely either an acute ex-
acerbation of CCPA or a SAIA, which could not be distinguished as our
patient had no prior medical history apart from the very recent diag-
nosis of COPD. Immunological function tests showed impairment in
both innate and adaptive immune system in our patient, which could
either be an indication of a previously undiagnosed immune deﬁciency,
or could be attributed to high dose of corticosteroid use. In view of the
high mortality, a history of COPD, unresponsiveness to antibiotics and
especially a suggestive CT-scan should trigger the clinician to consider
diseases caused by opportunistic pathogens, such as Aspergillus species,
to prevent treatment delays.
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